Effect of Lactobacillus rhamnosus GG and Vitamin D supplementation on the immunologic effectiveness of grassspecific sublingual immunotherapy in children with allergy

Allergy and Asthma Proceedings

Volumn 37, Issue 4, 2016, Pages 324-334

  Jerzynska, Joanna ^a   Stelmach, Wlodzimierz ^a   Balcerak, Joanna ^a   Woicka Kolejwa, Katarzyna ^a   Rychlik, Blazej ^b   Blauz, Andrzej ^b   Wachulec, Marcin ^b   Stelmach, Piotr ^a   Majak, Pawel ^a   Stelmach, Iwona ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; IMMUNOLOGIC AGENT; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; PLACEBO; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; VITAMIN D; ALLERGEN; BIOLOGICAL MARKER;

ALLERGIC RHINITIS; ARTICLE; CHILD; CHILD HEALTH; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GRASS POLLEN; HEADACHE; HUMAN; IMMUNE RESPONSE; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MOUTH DISEASE; PREDICTION; PROTEIN INDUCTION; RANDOMIZED CONTROLLED TRIAL; STOMACH PAIN; SUBLINGUAL IMMUNOTHERAPY; SUBLINGUAL ITCHING; CASE CONTROL STUDY; CLINICAL TRIAL; DIETARY SUPPLEMENT; FEMALE; IMMUNOLOGY; LUNG FUNCTION TEST; MALE; POACEAE; POLLEN; POLLEN ALLERGY; PRESCHOOL CHILD; PROCEDURES; PROGNOSIS; SEASON; TREATMENT OUTCOME;

ALLERGENS; BIOMARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; LACTOBACILLUS RHAMNOSUS; MALE; POACEAE; POLLEN; PROBIOTICS; PROGNOSIS; RESPIRATORY FUNCTION TESTS; RHINITIS, ALLERGIC, SEASONAL; SEASONS; SUBLINGUAL IMMUNOTHERAPY; TREATMENT OUTCOME; VITAMIN D;

EID: 84978864782     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2016.37.3958     Document Type: Article

References (52)

1. Durham SR, and Penagos M. Sublingual or subcutaneous immunotherapy for allergic rhinitis? J Allergy Clin Immunol 137: 339-349.e10, 2016.
2. Li JT, Bernstein DI, and Calderon MA. Sublingual grass and ragweed immunotherapy: Clinical considerations - A PRACTALL consensus report. J Allergy Clin Immunol 137:369-376, 2016.
3. Serra HM, Alignani DO, Passalacqua G, et al. What do we need to learn to optimize the SLIT alternative. Eur Ann Allergy Clin Immunol 38:158-165, 2006.
4. Jay DC, and Nadeau KC. Immune mechanisms of sublingual immunotherapy. Curr Allergy Asthma Rep 14:473, 2014.
5. Van Overtvelt L, Lombardi V, Razafindratsita A, et al. IL-10- inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model. Int Arch Allergy Immunol 145:152-162, 2008.
6. Kalliomäki M, Salminen S, Poussa T, et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361:1869-1871, 2003.
7. Ozdemir O. Any benefits of probiotics in allergic disorders? Allergy Asthma Proc 31:103-111, 2010.
8. Moussu H, Van Overtvelt L, Horiot S, et al. Bifidobacterium bifidum NCC 453 promotes tolerance induction in murine models of sublingual immunotherapy. Int Arch Allergy Immunol 158:35-42, 2012.
9. Miraglia Del Giudice M, Indolfi C, Allegorico A, et al. Probiotics and allergic respiratory diseases. J Biol Regul Homeost Agents 29(suppl. 1):80-83, 2015.
10. Yang G, Liu ZQ, and Yang PC. Treatment of allergic rhinitis with probiotics: An alternative approach. N Am J Med Sci 5:465-468, 2013.
11. Tang RB, Chang JK, and Chen HL. Can probiotics be used to treat allergic diseases? J Chin Med Assoc 78:154-157, 2015.
12. Gern JE. Promising candidates for allergy prevention. J Allergy Clin Immunol 136:23-28, 2015.
13. Turner JH, Adams AS, and Zajac A. Probiotics in prevention and treatment of allergic rhinitis. Am J Rhinol Allergy 29:224, 2015.
14. Majak P, Jerzyńska J, Smejda K, et al. Correlation of vitamin D with Foxp3 induction and steroid-sparing effect of immunotherapy in asthmatic children. Ann Allergy Asthma Immunol 109:329-335, 2012.
15. Sandhu MS, and Casale TB. The role of vitamin D in asthma. Ann Allergy Asthma Immunol 105:191-199; quiz 200-202, 217, 2010.
16. Chambers ES, Nanzer AM, and Richards DF. Serum 25-dihydroxyvitamin D levels correlate with CD4(+)Foxp3(+) T-cell numbers in moderate/severe asthma. J Allergy Clin Immunol 130:542-544, 2012.
17. Urry Z, Xystrakis E, Richards DF, et al. Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function. J Clin Invest 119:387-398, 2009.
18. Heine G, Tabeling C, Hartmann B, et al. 25-hydroxvitamin D3 promotes the long-term effect of specific immunotherapy in a murine allergy model. J Immunol 193:1017-1023, 2014.
19. Baris S, Kiykim A, Ozen A, et al. Vitamin D as an adjunct to subcutaneous allergen immunotherapy in asthmatic children sensitized to house dust mite. Allergy 69:246-253, 2014.
20. Hollams EM. Vitamin D, atopy and asthma phenotypes in children. Curr Opin Allergy Clin Immunol 12:228-234, 2012.
21. Chinellato I, Piazza M, Sandri M, et al. Serum vitamin D levels and exercise-induced bronchoconstriction in children with asthma. Eur Respir J 37:1366-1370, 2011.
22. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN∗and AllerGen∗∗). Allergy 63:8-160, 2008.
23. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. NIH publication no. 02-3659. January 1995, updated 2008. Available online at www.ginasthma.com/download.asp?intId-345; accessed February 20, 2014.
24. Alvarez-Cuesta E, Bousquet J, Canonica GW, et al. Standards for practical allergen-specific immunotherapy. Allergy 61(suppl. 82):1-20, 2006.
25. Web site of The Medical University of Lodz. Available online at www.umed.pl; accessed September 2, 2014.
26. Wasserfallen JB, Gold K, Schulman KA, and Baraniuk JN. Development and validation of a rhinoconjunctivitis and asthma symptom score for use as an outcome measure in clinical trials. J Allergy Clin Immunol 100:16-22, 1997.
27. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 26:319-338, 2005.
28. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 160:2104-2117, 1999.
29. Valovirta E, Jacobsen L, Ljorring C, et al. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Allergy 61:1177-1183, 2006.
30. Akdis M, Verhagen J, Taylor A, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 199:1567-1575, 2004.
31. Kücüksezer UC, Palomares O, Rückert B, et al. Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood. J Allergy Clin Immunol 131:875-885, 2013.
32. Scadding GW, Shamji MH, Jacobson MR, et al. Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells. Clin Exp Allergy 40:598-606, 2010.
33. Nouri-Aria KT, Wachholz PA, Francis JN, et al. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol 172:3252-3259, 2004.
34. Hatakka K, Savilahti E, Pönkä A, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: Double blind, randomised trial. BMJ 322:1327, 2001.
35. Ciprandi G, Vizzaccaro A, Cirillo I, and Tosca MA. Bacillus clausii effects in children with allergic rhinitis. Allergy 60:702-703, 2005.
36. Viljanen M, Kuitunen M, Haahtela T, et al. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr Allergy Immunol 16:65-71, 2005.
37. Konieczna P, Akdis CA, Quigley EM, et al. Portrait of an immunoregulatory Bifidobacterium. Gut Microbes 3:261-266, 2012.
38. Scheurer S, Toda M, and Vieths S. What makes an allergen? Clin Exp Allergy 45:1150-1161, 2015.
39. Devillier P, Dreyfus JF, Demoly P, and Calderon MA. A metaanalysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis. BMC Med 12:71, 2014.
40. Calderon MA, Birk AO, Andersen JS, and Durham SR. Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy. Allergy 62:958-961, 2007.
41. Malling HJ. Immunotherapy as an effective tool in allergy treatment. Allergy 53:461-472, 1998.
42. Didier A, Wahn U, Horak F, and Cox LS. Five-grass-pollen sublingual immunotherapy tablet for the treatment of grasspollen- induced allergic rhinoconjunctivitis: 5 years of experience. Expert Rev Clin Immunol 10:1309-1324, 2014.
43. Olaguíbel JM, and Alvarez Puebla MJ. Efficacy of sublingual allergen vaccination for respiratory allergy in children. Conclusions from one meta-analysis. J Investig Allergol Clin Immunol 15:9-16, 2005.
44. Penagos M, Passalacqua G, Compalati E, et al. Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 133:599-609, 2008.
45. Bousquet J, Schünemann HJ, Bousquet PJ, et al. How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: An ARIA-GA(2) LEN statement. Allergy 66:765-774, 2011.
46. Schuijs MJ, Willart MA, Vergote K, et al. Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells. Science 349:1106-1110, 2015.
47. Willart MA, Deswarte K, Pouliot P, et al. Interleukin-1α controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J Exp Med 209: 1505-1517, 2012.
48. Yenigun A, Dadaci Z, and Oncel M. Plasma vitamin D levels of patients with allergic rhino-conjunctivitis with positive skin prick test. Am J Rhinol Allergy 29:e46-e49, 2015.
49. Jerzynska J, Stelmach W, Rychlik B, et al. The clinical effect of vitamin D supplementation combined with grass-specific SLIT in children with allergic rhinitis. Allergy Asthma Proc 37:105-114, 2016.
50. Cantorna MT. Mechanisms underlying the effect of vitamin D on the immune system. Proc Nutr Soc 69:286-289, 2010.
51. Majak P, Rychlik B, and Stelmach I. The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children. Clin Exp Allergy 39:1830-1841, 2009.
52. Taher YA, van Esch BC, Hofman GA, et al. 1alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: Role for IL-10 and TGF-beta. J Immunol 180:5211-5221, 2008.